D. Montani, E. M. Lau, P. Dorfmüller, B. Girerd, X. Jaïs et al., Pulmonary veno-occlusive disease, Eur Respir J, vol.47, pp.1518-1534, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02561102

D. Montani, B. Girerd, X. Jaïs, M. Levy, D. Amar et al., Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study, Lancet Respir Med, vol.5, pp.125-134, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01436297

M. Eyries, D. Montani, B. Girerd, C. Perret, A. Leroy et al., EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension, Nat Genet, vol.46, pp.65-69, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01514453

D. Montani, E. Lau, A. Descatha, and M. Humbert, Pulmonary veno-occlusive disease as an occupational lung disease, Lancet Respir Med, vol.5, p.19, 2017.

B. Ravishankar, H. Liu, R. Shinde, K. Chaudhary, X. W. Bradley et al., The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity, Proc Natl Acad Sci U S A, vol.112, pp.10774-10779, 2015.

D. Santos-ribeiro, L. Godinas, C. Pilette, and F. Perros, The integrated stress response system in cardiovascular disease, Drug Discov Today, vol.23, pp.920-929, 2018.

C. Lathen, Y. Zhang, J. Chow, M. Singh, G. Lin et al., ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease, Circulation, vol.130, pp.1179-1191, 2014.

F. Perros, S. Günther, B. Ranchoux, L. Godinas, F. Antigny et al., Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models, Circulation, vol.132, pp.834-847, 2015.

S. Dey, C. M. Sayers, I. I. Verginadis, S. L. Lehman, Y. Cheng et al., ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis, J Clin Invest, vol.125, pp.2592-2608, 2015.

L. Ma and W. K. Chung, The genetic basis of pulmonary arterial hypertension, Hum Genet, vol.133, pp.471-479, 2014.

W. Zhang and H. T. Liu, MAPK signal pathways in the regulation of cell proliferation in mammalian cells, Cell Res, vol.12, pp.9-18, 2002.

A. Fabrice, R. Benoît, N. Valérie, E. Lau, B. Sébastien et al., A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat, Anal Cell Pathol Amst, p.326385, 2015.

M. Lambert, V. Capuano, A. Olschewski, J. Sabourin, C. Nagaraj et al., Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?, Int J Mol Sci, vol.19, 2018.

F. Antigny, A. Hautefort, J. Meloche, M. Belacel-ouari, B. Manoury et al., Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension, Circulation, vol.133, pp.1371-1385, 2016.

M. Lambert, V. Capuano, A. Boet, L. Tesson, T. Bertero et al., Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension, Circ Res, vol.125, pp.678-695, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02346635

S. Eddahibi, C. Guignabert, A. Barlier-mur, L. Dewachter, E. Fadel et al., Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia, Circulation, vol.113, pp.1857-1864, 2006.

W. Yuan, S. Guo, J. Gao, M. Zhong, G. Yan et al., General Control Nonderepressible 2 (GCN2) Kinase Inhibits Target of Rapamycin Complex 1 in Response to Amino Acid Starvation in Saccharomyces cerevisiae, J Biol Chem, vol.292, pp.2660-2669, 2017.

Z. Deng, X. Lei, X. Zhang, H. Zhang, S. Liu et al., mTOR signaling promotes stem cell activation via counterbalancing BMPmediated suppression during hair regeneration, J Mol Cell Biol, vol.7, pp.62-72, 2015.

E. Spiekerkoetter, X. Tian, J. Cai, R. K. Hopper, D. Sudheendra et al., Ten Dijke P, Rabinovitch M. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension, J Clin Invest, vol.123, pp.3600-3613, 2013.

G. G. Pietra, F. Capron, S. Stewart, O. Leone, M. Humbert et al., Pathologic assessment of vasculopathies in pulmonary hypertension, J Am Coll Cardiol, vol.43, pp.25-32, 2004.

M. Ghigna, C. Guignabert, D. Montani, B. Girerd, X. Jaïs et al., BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension, Eur Respir J, vol.48, pp.1668-1681, 2016.

E. J. Nossent, F. Antigny, D. Montani, H. J. Bogaard, M. R. Ghigna et al., Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary venoocclusive disease, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, 2017.

A. Olschewski, E. L. Veale, B. M. Nagy, C. Nagaraj, G. Kwapiszewska et al., TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications, Eur Respir J, vol.50, 2017.

A. U. Fayyaz, W. D. Edwards, J. J. Maleszewski, E. A. Konik, H. M. Dubrock et al., Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction, Circulation, vol.137, pp.1796-1810, 2018.

V. B. Pai and M. C. Nahata, Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention, Drug Saf, vol.22, pp.263-302, 2000.

P. Naing, H. Kuppusamy, G. Scalia, G. S. Hillis, and D. Playford, Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future Direction, Heart Lung Circ, vol.26, pp.323-330, 2017.

P. T. Levy, M. D. Patel, S. Choudhry, A. Hamvas, and G. K. Singh, Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age, J Pediatr, vol.197, pp.48-56, 2018.

B. Tielemans, M. Delcroix, C. Belge, and R. Quarck, TGF? and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension, Drug Discov Today, vol.24, pp.703-716, 2019.

D. Bach, H. J. Park, and S. K. Lee, The Dual Role of Bone Morphogenetic Proteins in Cancer, Mol Ther Oncolytics, vol.8, pp.1-13, 2018.

D. Prosseda, S. Tian, X. Kuramoto, K. Boehm, M. Sudheendra et al., FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension, Am J Respir Crit Care Med, vol.199, pp.83-98, 2019.

J. West, J. Cogan, M. Geraci, L. Robinson, J. Newman et al., Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance, BMC Med Genomics, vol.1, p.45, 2008.

Y. Suzuki, N. Ohga, Y. Morishita, K. Hida, K. Miyazono et al., BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo, J Cell Sci, vol.123, pp.1684-1692, 2010.

M. Scharpfenecker, M. Van-dinther, Z. Liu, R. L. Van-bezooijen, Q. Zhao et al.,

P. Dijke, BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis, J Cell Sci, vol.120, pp.964-972, 2007.

K. S. Awad, J. M. Elinoff, S. Wang, S. Gairhe, G. A. Ferreyra et al.,

, Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells, Am J Physiol Lung Cell Mol Physiol, vol.310, pp.187-201, 2016.

M. Barrios-rodiles, K. R. Brown, B. Ozdamar, R. Bose, Z. Liu et al., High-throughput mapping of a dynamic signaling network in mammalian cells, Science, vol.307, pp.1621-1625, 2005.

Y. Wu, A. D. Long, M. Wang, J. Liu, F. Gai et al., 4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in Rats, PloS One, vol.11, p.157538, 2016.

S. Günther, F. Perros, P. Rautou, B. Girerd, M. Ghigna et al., Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease, Am J Pathol, vol.189, pp.1159-1175, 2019.

R. D. , Translational control in the endoplasmic reticulum stress response, J Clin Invest, vol.110, pp.1383-1388, 2002.

, A novel mechanism for the control of translation initiation by amino acids, mediated by phosphorylation of eukaryotic initiation factor 2B. -PubMed -NCBI

C. W. Woo, L. Kutzler, S. R. Kimball, and I. Tabas, Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B, Nat Cell Biol, vol.14, pp.192-200, 2012.

S. L. Lehman, S. Ryeom, and C. Koumenis, Signaling through alternative Integrated Stress Response pathways compensates for GCN2 loss in a mouse model of soft tissue sarcoma, Sci Rep, vol.5, p.11781, 2015.

D. Wanders, K. P. Stone, L. A. Forney, C. C. Cortez, K. N. Dille et al., Role of GCN2-Independent Signaling Through a Noncanonical PERK/NRF2 Pathway in the Physiological Responses to Dietary Methionine Restriction, Diabetes, vol.65, pp.1499-1510, 2016.

Z. Zong, Z. Du, N. Li, C. Li, Q. Zhang et al., Implication of Nrf2 and ATF4 in differential induction of CHOP by proteasome inhibition in thyroid cancer cells, Biochim Biophys Acta, vol.1823, pp.1395-1404, 2012.

Y. Chen, T. Yuan, H. Zhang, Y. Yan, D. Wang et al., Activation of Nrf2 Attenuates Pulmonary Vascular Remodeling via Inhibiting Endothelial-to-Mesenchymal Transition: an Insight from a Plant Polyphenol, Int J Biol Sci, vol.13, pp.1067-1081, 2017.

V. Nikolova-krstevski, L. Yuan, L. Bras, A. Vijayaraj, P. Kondo et al., ERG is required for the differentiation of embryonic stem cells along the endothelial lineage, BMC Dev Biol, vol.9, p.72, 2009.

S. J. Loughran, E. A. Kruse, D. F. Hacking, C. A. De-graaf, C. D. Hyland et al., The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells, Nat Immunol, vol.9, pp.810-819, 2008.

A. P. Looney, R. Han, L. Stawski, G. Marden, M. Iwamoto et al., Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis, Am J Respir Cell Mol Biol, vol.57, pp.121-131, 2017.

S. E. Verleden, D. M. Vasilescu, S. Willems, D. Ruttens, R. Vos et al., The site and nature of airway obstruction after lung transplantation, Am J Respir Crit Care Med, vol.189, pp.292-300, 2014.

C. J. Jung, S. Ménoret, L. Brusselle, L. Tesson, C. Usal et al., Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of, Humanized SIRPA Rats. Sci Rep, vol.6, p.31455, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150699

S. Ménoret, A. De-cian, L. Tesson, R. S. Usal, C. Boulé et al., Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins, Sci Rep, vol.5, p.14410, 2015.

V. Chenouard, L. Brusselle, J. Heslan, R. S. Ménoret, S. Usal et al., A Rapid and Cost-Effective Method for Genotyping Genome-Edited Animals: A Heteroduplex Mobility Assay Using Microfluidic Capillary Electrophoresis, J Genet Genomics, vol.43, pp.341-348, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150677

F. Perros, S. Günther, B. Ranchoux, L. Godinas, F. Antigny et al., Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models, Circulation, vol.132, pp.834-847, 2015.

P. T. Levy, M. D. Patel, S. Choudhry, A. Hamvas, and G. K. Singh, Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age, J Pediatr, vol.197, pp.48-56, 2018.

P. Naing, H. Kuppusamy, G. Scalia, G. S. Hillis, and D. Playford, Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future Direction, Heart Lung Circ, vol.26, pp.323-330, 2017.

M. Lambert, A. Boet, C. Rucker-martin, P. Mendes-ferreira, V. Capuano et al., Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension, Cardiovasc Res, vol.114, pp.880-893, 2018.

B. Ranchoux, S. Günther, R. Quarck, M. Chaumais, P. Dorfmüller et al.,

M. , M. D. Perros, and F. , Chemotherapy-induced pulmonary hypertension: role of alkylating agents

, Am J Pathol, vol.185, pp.356-371, 2015.

F. Antigny, A. Hautefort, J. Meloche, M. Belacel-ouari, B. Manoury et al.,

M. and P. F. , Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension, Circulation, vol.133, pp.1371-1385, 2016.

C. Putzke, K. Wemhöner, F. B. Sachse, S. Rinné, G. Schlichthörl et al., The acid-sensitive potassium channel TASK-1 in rat cardiac muscle, Cardiovasc Res, vol.75, pp.59-68, 2007.

S. J. Dumas, G. Bru-mercier, A. Courboulin, M. Quatredeniers, C. Rücker-martin et al., NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension, Circulation, vol.137, pp.2371-2389, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02411759

L. Long, M. L. Ormiston, X. Yang, M. Southwood, S. Gräf et al., Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension, Nat Med, vol.21, pp.777-785, 2015.

E. Spiekerkoetter, X. Tian, J. Cai, R. K. Hopper, D. Sudheendra et al., Ten Dijke P, Rabinovitch M. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension, J Clin Invest, vol.123, pp.3600-3613, 2013.

L. E. Watson, M. Sheth, R. F. Denyer, and D. E. Dostal, Baseline echocardiographic values for adult male rats, J Am Soc Echocardiogr, vol.17, pp.161-167, 2004.

R. Hayward and D. S. Hydock, Doxorubicin cardiotoxicity in the rat: an in vivo characterization, J Am Assoc Lab Anim Sci, vol.46, pp.20-32, 2007.